Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Farmers Insurance
AstraZeneca
Chinese Patent Office
Covington
Merck
Novartis
Healthtrust
Teva

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022462

« Back to Dashboard

NDA 022462 describes GABLOFEN, which is a drug marketed by Piramal Critical and is included in one NDA. It is available from two suppliers. Additional details are available on the GABLOFEN profile page.

The generic ingredient in GABLOFEN is baclofen. There are eighteen drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the baclofen profile page.
Summary for 022462
Tradename:GABLOFEN
Applicant:Piramal Critical
Ingredient:baclofen
Patents:0
Therapeutic Class:Antispasticity Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 022462
Medical Subject Heading (MeSH) Categories for 022462
Suppliers and Packaging for NDA: 022462
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GABLOFEN baclofen INJECTABLE;INTRATHECAL 022462 NDA Mallinckrodt Inc (Brand Pharmaceuticals) 45945-155 N 45945-155-02
GABLOFEN baclofen INJECTABLE;INTRATHECAL 022462 NDA Mallinckrodt Inc (Brand Pharmaceuticals) 45945-155 N 45945-155-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRATHECALStrength0.05MG/ML
Approval Date:Nov 19, 2010TE:APRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRATHECALStrength0.5MG/ML
Approval Date:Nov 19, 2010TE:APRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRATHECALStrength2MG/ML
Approval Date:Nov 19, 2010TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Merck
Chinese Patent Office
Medtronic
Dow
Harvard Business School
Deloitte
McKinsey
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot